Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of Child Health and Human Development
  • Lucile Packard Foundation
  • Stanford CTSA (UL1 TR001085)
  • Stanford University
  • American Academy of Allergy Asthma and Immunology
  • National Institutes of Health (K08 AI080945)
  • Stanford Child Health Research Institute
  • Arthritis Foundation
  • NIH (R01 AI083757, R01 AI100121)
  • Damon Runyon Cancer Research Foundation (DRG-2017-09)
  • NIH (R00 GM104148-03)
  • NIH (U19AI057229, U19AI090019, U54CA149145, T32AI007290, N01-HV-00242, 1U19AI100627, 5R01AI073724, R01CA184968, R33CA183654, R33CA183692)
  • NIH–Baylor Research Institute (41000411217)
  • NIH–Northrop Grumman Corp (7500108142)
  • California Institute for Regenerative Medicine (DR1-01477)
  • US Food and Drug Administration (HHSF223201210194C)
  • Bill and Melinda Gates Foundation (OPP1113682)
  • European Commission (HEALTH.2010.1.2-1)
  • Alliance for Lupus Research
  • Entertainment Industry Foundation
  • US Department of Defense (OC110674, 11491122)
  • Howard Hughes Medical Institute